Sign in
CompletedNo phase

Validation of a Hypoparathyroidism Self-questionnaire

Key facts

Who runs it
Nantes University Hospital
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
81 people enrolled
Started
2 May 2023
Ended
10 Dec 2023
Type of study
Observational
Treatments tested
  • Response to medical and research questionnaires
Record updated
19 September 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Major patient
  • Patients undergoing total thyroidectomy
  • Patients with permanent hypoparathyroidism defined by a parathyroid hormone concentration ≤ 25 pg/mL more than 6 months after surgery and who require vitamin and calcium therapy
  • Not being opposed to participating in the study (questionnaires will be sent with the study information note. If the patient returns the questionnaires: we will consider that he/she is not opposed to participate in this study)
  • Participants must be affiliated to a social security system

Who cannot take part

  • Patients on long-term vitamin-calcium therapy after total thyroidectomy whose PTH concentration has not been controlled or whose concentration is higher than 25 pg/mL
  • Pregnant women when filling out questionnaires (the child's parathyroids can correct the mother's hypoparathyroidism)
  • Minors or protected patients (under guardianship)
  • Patients under court protection
  • Hypoparathyroid patients of other origin than post-thyroidectomy

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to evaluate, for patients with post-thyroidectomy hypoparathyroidism (HoPT), the severity of their HoPT and to validate clinical scores from a self-administered questionnaire related to this disease (questionnaire which evaluates the severity of clinical symptoms related to HoPT and their impact on quality of life) in order to assess the severity of HoPT and to optimize support.

The group in the trial

  • Hypoparathyroidism after total thyroidectomy

    Adult patients definitive post-thyroidectomy HoPT defined by a parathyroid hormone (PTH) concentration ≤ 25 pg/mL more than 6 months after the operation and who require treatment with vitamin D and/or calcium supplementation. Each patient will complete a questionnaire twice (3 weeks apart +/- 7 days). The questionnaire, which evaluates the severity of clinical symptoms related to HoPT and their impact on quality of life, is adapted to this pathology.

    Treatment: Response to medical and research questionnaires

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Validation of a Self-questionnaire to Assess the Severity of Clinical Symptoms Related to Post-thyroidectomy Hypoparathyroidism
Record updated
19 September 2024